MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
Researchers from the Department of Energy's Quantum Science Center (QSC) headquartered at Oak Ridge National Laboratory (ORNL ...
Physics is the search for and application of rules that can help us understand and predict the world around us. Central to physics are ideas such as energy, mass, particles and waves. Physics attempts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results